Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

被引：79
作者：
Czuczman, MS
Fallon, A
Mohr, A
Stewart, C
Bernstein, ZP
McCarthy, P
Skipper, M
Brown, K
Miller, K
Wentling, D
Klippenstein, D
Loud, P
Rock, MK
Benyunes, M
Grillo-López, AJ
Bernstein, SH
机构：
[1] Roswell Pk Canc Inst, Div Hematol Oncol, Lymphoma Serv, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Div Bone Marrow Transplantat, Lymphoma Serv, Buffalo, NY 14263 USA
[3] Berlex Labs Inc, Richmond, CA USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] IDEC Pharmaceut, San Diego, CA USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36 / 40
页数：5
相关论文
共 6 条
  • [1] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
    Czuczman, MS
    Grillo-López, AJ
    White, CA
    Saleh, M
    Gordon, L
    LoBuglio, AF
    Jonas, C
    Klippenstein, D
    Dallaire, B
    Varns, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 268 - 276
  • [2] Czuczman MS, 2000, BLOOD, V96, p729A
  • [3] Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs
    Demidem, A
    Lam, T
    Alas, S
    Hariharan, K
    Hanna, N
    Bonavida, B
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) : 177 - 186
  • [4] Grillo-López AJ, 1999, SEMIN ONCOL, V26, P66
  • [5] Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: A multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte
    SolalCeligny, P
    Brice, P
    Brousse, N
    Caspard, H
    Bastion, Y
    Haioun, C
    Bosly, A
    Tilly, H
    Bordessoule, D
    Sebban, C
    Harousseau, JL
    Morel, P
    Dupas, B
    Plassart, F
    Vasile, N
    Fort, N
    Leporrier, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 514 - 519
  • [6] XIAO YM, 2000, HEMATOL J S1, V1, P63
1